Correlation Between Immunome and Mereo BioPharma
Can any of the company-specific risk be diversified away by investing in both Immunome and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immunome and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immunome and Mereo BioPharma Group, you can compare the effects of market volatilities on Immunome and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immunome with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immunome and Mereo BioPharma.
Diversification Opportunities for Immunome and Mereo BioPharma
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Immunome and Mereo is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Immunome and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and Immunome is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immunome are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of Immunome i.e., Immunome and Mereo BioPharma go up and down completely randomly.
Pair Corralation between Immunome and Mereo BioPharma
Given the investment horizon of 90 days Immunome is expected to generate 1.61 times more return on investment than Mereo BioPharma. However, Immunome is 1.61 times more volatile than Mereo BioPharma Group. It trades about 0.14 of its potential returns per unit of risk. Mereo BioPharma Group is currently generating about -0.18 per unit of risk. If you would invest 1,159 in Immunome on September 2, 2024 and sell it today you would earn a total of 196.00 from holding Immunome or generate 16.91% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Immunome vs. Mereo BioPharma Group
Performance |
| Timeline |
| Immunome |
| Mereo BioPharma Group |
Immunome and Mereo BioPharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Immunome and Mereo BioPharma
The main advantage of trading using opposite Immunome and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immunome position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.| Immunome vs. Anebulo Pharmaceuticals | Immunome vs. Adagene | Immunome vs. Acrivon Therapeutics, Common | Immunome vs. AnaptysBio |
| Mereo BioPharma vs. Terns Pharmaceuticals | Mereo BioPharma vs. PDS Biotechnology Corp | Mereo BioPharma vs. Inozyme Pharma | Mereo BioPharma vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |